JY231(JY231) Injection for the Treatment of Relapsed or Refractory B Cell Lymphoma/ Leukemia
Abroad (travel likely)Recruiting
Conditions
B-NHL · B-ALL
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
The First Affiliated Hospital of Zhengzhou University, Zhenzhou, Henan, China
Study leads
Yi Zhang, Doctor
Principal Investigator
The First Affiliated Hospital of Zhengzhou University